CYTK
Price
$32.00
Change
+$0.79 (+2.53%)
Updated
Jun 3 closing price
Capitalization
3.82B
57 days until earnings call
KRON
Price
$0.68
Change
+$0.01 (+1.49%)
Updated
Jun 3 closing price
Capitalization
41.46M
64 days until earnings call
Interact to see
Advertisement

CYTK vs KRON

Header iconCYTK vs KRON Comparison
Open Charts CYTK vs KRONBanner chart's image
Cytokinetics
Price$32.00
Change+$0.79 (+2.53%)
Volume$1.26M
Capitalization3.82B
Kronos Bio
Price$0.68
Change+$0.01 (+1.49%)
Volume$769.47K
Capitalization41.46M
CYTK vs KRON Comparison Chart
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYTK vs. KRON commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a Buy and KRON is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (CYTK: $32.00 vs. KRON: $0.68)
Brand notoriety: CYTK and KRON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 55% vs. KRON: 111%
Market capitalization -- CYTK: $3.82B vs. KRON: $41.46M
CYTK [@Biotechnology] is valued at $3.82B. KRON’s [@Biotechnology] market capitalization is $41.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 0 FA rating(s) are green whileKRON’s FA Score has 1 green FA rating(s).

  • CYTK’s FA Score: 0 green, 5 red.
  • KRON’s FA Score: 1 green, 4 red.
According to our system of comparison, KRON is a better buy in the long-term than CYTK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 5 TA indicator(s) are bullish while KRON’s TA Score has 5 bullish TA indicator(s).

  • CYTK’s TA Score: 5 bullish, 2 bearish.
  • KRON’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CYTK is a better buy in the short-term than KRON.

Price Growth

CYTK (@Biotechnology) experienced а +4.81% price change this week, while KRON (@Biotechnology) price change was -1.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.76%. For the same industry, the average monthly price growth was +2.77%, and the average quarterly price growth was +0.74%.

Reported Earning Dates

CYTK is expected to report earnings on Jul 31, 2025.

KRON is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+5.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($3.82B) has a higher market cap than KRON($41.5M). KRON YTD gains are higher at: -28.421 vs. CYTK (-31.973). KRON has higher annual earnings (EBITDA): -49.14M vs. CYTK (-513.62M). CYTK has more cash in the bank: 938M vs. KRON (99.7M). KRON has less debt than CYTK: KRON (24.1M) vs CYTK (791M). CYTK has higher revenues than KRON: CYTK (19.2M) vs KRON (9.19M).
CYTKKRONCYTK / KRON
Capitalization3.82B41.5M9,210%
EBITDA-513.62M-49.14M1,045%
Gain YTD-31.973-28.421112%
P/E RatioN/AN/A-
Revenue19.2M9.19M209%
Total Cash938M99.7M941%
Total Debt791M24.1M3,282%
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
79
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYTKKRON
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 6 days ago
77%
Declines
ODDS (%)
Bearish Trend 8 days ago
78%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IESC271.807.65
+2.90%
IES Holdings
LOCO10.700.29
+2.79%
El Pollo Loco Holdings
ASRV2.960.04
+1.37%
AmeriServ Financial
GEL15.870.01
+0.06%
Genesis Energy LP
REGN487.86-2.95
-0.60%
Regeneron Pharmaceuticals

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with KRYS. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
+2.53%
KRYS - CYTK
47%
Loosely correlated
+4.43%
IDYA - CYTK
47%
Loosely correlated
+1.98%
TRDA - CYTK
44%
Loosely correlated
+1.23%
ROIV - CYTK
44%
Loosely correlated
+0.67%
ACLX - CYTK
44%
Loosely correlated
+5.18%
More

KRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRON has been loosely correlated with CYTK. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if KRON jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRON
1D Price
Change %
KRON100%
+1.72%
CYTK - KRON
42%
Loosely correlated
+2.53%
VERA - KRON
38%
Loosely correlated
-2.61%
AXON - KRON
38%
Loosely correlated
+0.07%
ARRY - KRON
37%
Loosely correlated
+6.53%
BTAI - KRON
36%
Loosely correlated
+3.79%
More